• Patricio Flores, PhD in Biotechnology, and Yu-Wen Tang, student at the Master´s program in Technology Management- Major in Biotechnology, both from the Faculty of Chemistry and Biology, were awarded a grant to develop a strategy for marketing an enzyme that has multiple benefits for diagnosing diseases.

As a result of the work they did for a doctoral dissertation and after being granted funds through the “Go To Market, de la Idea al Mercado” Contest organized by Corfo (the Chilean Economic Development Agency), the researchers will get trained in Silicon Valley, in the context of the third stage of the project “Developing a strategy for marketing a highly stable glutamate dehydrogenase (GLDH) enzyme.”

The project, which was developed under the guidance of Dr. Jenny Blamey, associate professor at Universidad de Santiago, proposes replacing the bovine GLDH enzyme with one from an Antarctic extremophilic microorganism (capable of resisting extreme conditions of temperature, pH, pressure, salinity, among others), which does not have the deficiencies of its predecessor. Its most common application is in the area of clinical laboratories where it is used for diagnosing hepatic and renal diseases

According to researcher Patricio Flores, “having discovered this new enzyme, glutamate dehydrogenase (GLDH), improves the half-life of five different types of diagnostic kits, as its thermal stability is higher than the one of the enzyme used today.” The academic stresses that “what is most important is that it also solves the problem of low half-life of the “old” diagnostic kits, preventing from discarding expired kits that have not been used, improving result reliability, lowering costs, reducing losses for companies and enabling a stock available to give a quick answer to market requirements.”

“The new enzyme is much more stable. It can be stored at room temperature, keeping more than 85% of its activity for 50 days. On the other hand, the bovine enzyme completely loses its activity under the same conditions,” Dr. Flores explains, regarding the results of this project that involves Universidad de Santiago and Fundación Científica y Cultural Biocencia.

Go To Market

“Go To Market, de la Idea al Mercado” is an initiative that seeks to identify research studies conducted at universities, technological centers and Chilean companies that have generated technologies that could potentially benefit the global market.

“The application process for the Corfo’s Go to Market Contest coincided with the last steps to finish my doctoral dissertation in which I developed the product prototype, that is to say, the GLDH enzyme from an Antarctic thermophilic microorganism,” Dr, Flores says.

At present, the project is at its third stage, which involves getting training at the Standford Research Institute (SRI), scheduling meetings with investors and interested clients and developing a marketing strategy to position the product in the market. These will be the activities that the two researchers will have while they stay in USA.

Translated by Marcela Contreras